Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02096029 · ClinicalTrials.gov registry record · NA
Tobacco Intervention in Primary Care Treatment Opportunities for Providers
A NA study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 1,278
- Enrollment target
NCT02096029: Completed NA study, sponsored by Medical University of South Carolina.
NCT02096029 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 1,278 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02096029, a NA study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,278 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the use of "sampling" of smoking cessation medications (nicotine patches and lozenges) among smokers seen in primary care settings. Half of study participants will be provided with samples of medication, to use however they wish; the other half will not be provided with these samples. All smokers will be advised to quit through routine contact with their physician. After the primary care contact, all participants will be contacted by phone for three brief follow-up interviews, which will involve answering questionnaires about their smoking habits.
Interventions
- OTHER Nicotine Replacement Therapy (NRT) Sampling
- BEHAVIORAL Ask, Advise, Refer (physician brief advice)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,278 participants |
| Start Date | 2014-07 |
| Est. Completion | 2018-06-15 |
| Phase | NA |
What the finished NCT02096029 record still lists
NCT02096029 is an interventional study that assigns participants to a tested intervention. Its 1,278 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.
The record links to 0 conditions, and to 2 interventions - of which Nicotine Replacement Therapy (NRT) Sampling is the first listed.
NCT02096029 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02096029 about?
NCT02096029 is a clinical study titled "Tobacco Intervention in Primary Care Treatment Opportunities for Providers". The purpose of this study is to evaluate the use of "sampling" of smoking cessation medications (nicotine patches and lozenges) among smokers seen in primary care settings. Half of study participants will be provided with samples of medication, to use however they wish; the other half will not be pr...
What is the current status of trial NCT02096029?
This trial is currently completed. It is a NA study. The enrollment target is 1,278 participants. The study started on 2014-07. Estimated completion is 2018-06-15.
What interventions are being tested in trial NCT02096029?
The interventions under investigation include: Nicotine Replacement Therapy (NRT) Sampling (OTHER), Ask, Advise, Refer (physician brief advice) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02096029?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02096029's enrollment target sits among peer trials
1,278 78th of 2000 higher than 1,923 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03970447 · 1,280 participants · Phase 2
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
- NCT06468228 · 1,280 participants · Phase 3
A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- NCT07207811 · 1,280 participants · Phase 3
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
- NCT07001800 · 1,276 participants · Phase 2
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia